MedPath
HSA Approval

TREXOFIN FOR INJECTION 2 g/vial

SIN11037P

TREXOFIN FOR INJECTION 2 g/vial

TREXOFIN FOR INJECTION 2 g/vial

July 21, 1999

ZYFAS MEDICAL CO

ZYFAS MEDICAL CO

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS MEDICAL CO
Licence HolderZYFAS MEDICAL CO

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01DD04

ceftriaxone

Manufacturer Information

ZYFAS MEDICAL CO

CJ CORP

Active Ingredients

CEFTRIAXONE SODIUM EQV CEFTRIAXONE

2 g/vial

Ceftriaxone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TREXOFIN FOR INJECTION 2 g/vial - HSA Approval | MedPath